(Total Views: 410)
Posted On: 03/29/2022 11:06:12 AM
Post# of 55

$SGMO News Article - Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation https://marketwirenews.com/news-releases/sang...88545.html


My Twitter: WhyteStocks